Morgan Stanley
SNV

Morgan Stanley’s Synovus SNV Stock Holding History

Morgan Stanley’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,683,475
Closed -$84.3M – 8486
2025
Q4 		$84.3M Buy
1,683,475
+4,857
+0.3% +$233K 0.01% 1596
2025
Q3 		$82.4M Sell
1,678,618
-159,745
-9% -$8.19M 0.01% 1575
2025
Q2 		$95.1M Buy
1,838,363
+190,316
+12% +$8.75M 0.01% 1365
2025
Q1 		$77M Sell
1,648,047
-276,497
-14% -$14.3M 0.01% 1437
2024
Q4 		$98.6M Buy
1,924,544
+51,361
+3% +$2.66M 0.01% 1257
2024
Q3 		$83.3M Sell
1,873,183
-26,144
-1% -$1.14M 0.01% 1386
2024
Q2 		$76.3M Buy
1,899,327
+181,882
+11% +$6.89M 0.01% 1377
2024
Q1 		$68.8M Buy
1,717,445
+127,392
+8% +$4.79M 0.01% 1468
2023
Q4 		$59.9M Sell
1,590,053
-190,223
-11% -$5.82M 0.01% 1545
2023
Q3 		$49.5M Buy
1,780,276
+110,407
+7% +$3.45M 0.01% 1590
2023
Q2 		$50.5M Sell
1,669,869
-72,106
-4% -$2.11M 0.01% 1570
2023
Q1 		$53.7M Sell
1,741,975
-76,989
-4% -$2.93M 0.01% 1481
2022
Q4 		$68.3M Sell
1,818,964
-92,322
-5% -$3.66M 0.01% 1267
2022
Q3 		$71.7M Sell
1,911,286
-129,415
-6% -$5.13M 0.01% 1081
2022
Q2 		$73.6M Buy
2,040,701
+454,128
+29% +$18.8M 0.01% 1111
2022
Q1 		$77.7M Sell
1,586,573
-135,907
-8% -$6.88M 0.01% 1027
2021
Q4 		$82.5M Buy
1,722,480
+20,936
+1% +$991K 0.01% 1010
2021
Q3 		$74.7M Buy
1,701,544
+213,661
+14% +$9.03M 0.01% 1020
2021
Q2 		$65.3M Buy
1,487,883
+190,830
+15% +$8.96M 0.01% 1130
2021
Q1 		$59.3M Buy
1,297,053
+37,974
+3% +$1.59M 0.01% 1054
2020
Q4 		$40.8M Buy
1,259,079
+227,175
+22% +$6.57M 0.01% 1235
2020
Q3 		$21.8M Buy
1,031,904
+130,692
+15% +$2.72M ﹤0.01% 1416
2020
Q2 		$18.5M Buy
901,212
+448,661
+99% +$8.68M ﹤0.01% 1464
2020
Q1 		$7.95M Buy
452,551
+164,115
+57% +$5.06M ﹤0.01% 1985
2019
Q4 		$11.3M Sell
288,436
-178,051
-38% -$6.54M ﹤0.01% 2294
2019
Q3 		$16.7M Buy
466,487
+258,995
+125% +$9.29M ﹤0.01% 1640
2019
Q2 		$7.26M Buy
207,492
+61,844
+42% +$2.15M ﹤0.01% 2513
2019
Q1 		$5M Buy
145,648
+21,419
+17% +$786K ﹤0.01% 2712
2018
Q4 		$3.97M Sell
124,229
-57,646
-32% -$2.17M ﹤0.01% 3153
2018
Q3 		$8.33M Sell
181,875
-28,643
-14% -$1.44M ﹤0.01% 2603
2018
Q2 		$11.1M Sell
210,518
-174,600
-45% -$9.28M ﹤0.01% 2257
2018
Q1 		$19.2M Sell
385,118
-126,797
-25% -$6.39M 0.01% 1697
2017
Q4 		$24.5M Buy
511,915
+157,939
+45% +$7.48M 0.01% 1491
2017
Q3 		$16.3M Sell
353,976
-228,514
-39% -$9.91M ﹤0.01% 1766
2017
Q2 		$25.8M Sell
582,490
-428,668
-42% -$18M 0.01% 1319
2017
Q1 		$41.5M Buy
1,011,158
+241,564
+31% +$10.1M 0.01% 1024
2016
Q4 		$31.6M Buy
769,594
+236,944
+44% +$8.71M 0.01% 1164
2016
Q3 		$17.3M Buy
532,650
+114,830
+27% +$3.61M 0.01% 1573
2016
Q2 		$12.1M Buy
417,820
+125,100
+43% +$3.8M ﹤0.01% 1817
2016
Q1 		$8.46M Buy
292,720
+159,733
+120% +$4.58M ﹤0.01% 2006
2015
Q4 		$4.31M Buy
132,987
+36,986
+39% +$1.18M ﹤0.01% 2808
2015
Q3 		$2.84M Sell
96,001
-119,032
-55% -$3.65M ﹤0.01% 3164
2015
Q2 		$6.63M Buy
215,033
+89,418
+71% +$2.59M ﹤0.01% 2542
2015
Q1 		$3.52M Sell
125,615
-37,774
-23% -$1.02M ﹤0.01% 3074
2014
Q4 		$4.43M Buy
163,389
+76,625
+88% +$1.94M ﹤0.01% 2845
2014
Q3 		$2.05M Sell
86,764
-2,017
-2% -$48.4K ﹤0.01% 3407
2014
Q2 		$2.17M Sell
88,781
-140,585
-61% -$3.28M ﹤0.01% 3427
2014
Q1 		$5.44M Buy
229,366
+4,045
+2% +$98.4K ﹤0.01% 2510
2013
Q4 		$5.68M Buy
225,321
+45,977
+26% +$1.08M ﹤0.01% 2458
2013
Q3 		$4.14M Buy
179,344
+45,593
+34% +$1.04M ﹤0.01% 2611
2013
Q2 		$2.73M Buy
+133,751
New +$2.53M ﹤0.01% 2887

Other funds holding SNV

WBWA
William B. Walkup & Associates Columbia, South Carolina $208M AUM 37.34% 1-Year Est. Return

Morgan Stanley's SNV Position: Q1 2026 in Review

Morgan Stanley sold out of Synovus (SNV) in Q1 2026, closing a stake of 1,683,475 shares — an estimated $84.3M sold.

Morgan Stanley first reported a position in SNV in Q2 2013 and held it in 51 quarters. The position peaked at $98.6M in Q4 2024. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Morgan Stanley reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 1,683,475 Synovus shares in Q1 2026, an estimated $84.3M.
  • Morgan Stanley first reported a position in Synovus in Q2 2013 and held it in 51 quarters.
  • Morgan Stanley's Synovus position peaked at $98.6M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.